All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2015-001918-98 | RATe control in Atrial Fibrillation II | 2021-11-12 | due-trials |
Ongoing | 2018-001863-21 | First-line treatment with osimertinib in EGFR-mutated non-small cell lung cancer, coupled to extensive translational studies | not-yet-due | |
Completed, but no date | 2018-004261-14 | MUscle Side-Effects of atorvastatin in coronary patients (MUSE) | bad-data | |
Ongoing | 2019-003959-11 | MUscle Side-Effects of atorvastatin in coronary patients (MUSE) follow-up study | not-yet-due | |
Ongoing | 2020-004920-40 | Affective effects of pre-surgery opioids (AFFECT): a randomized double-blind controlled trial | not-yet-due | |
Other | 2021-001696-16 | Sotorasib in advanced KRASG12C-mutated non-small cell lung cancer patients with comorbidities | not-yet-due | |
Other | 2021-005729-25 | A Randomized Phase II, Open-label, Multicenter Study Investigating Efficacy and Safety of anti-PD-1/PD-L1 treatment +/- UV1 vaccination as first line treatment in patients with inoperable advanced or ... | not-yet-due |